Development of Autoantibodies in the TrialNet Natural History Study

OBJECTIVE: Understanding the relationship between age and islet autoantibody (Ab) seroconversion can establish the optimal screening interval(s) to assess risk for type 1 diabetes, identify subjects who can participate in prevention trials, and determine associated costs. This study assessed the rat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Vehik, Kendra, Beam, Craig A., Mahon, Jeffrey L., Schatz, Desmond A., Haller, Michael J., Sosenko, Jay M., Skyler, Jay S., Krischer, Jeffrey P.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Diabetes Association 2011
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3161292/
https://ncbi.nlm.nih.gov/pubmed/21750277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc11-0560
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge